News

News

Converge is recognized in most groundbreaking AI startups by Greenfield Partners and TechCrunch!

Converge is recognized in most groundbreaking AI startups by Greenfield Partners and TechCrunch!

|

Dec 22, 2025

Research and Updates

Resources Page

Blog

Solubility: The Quiet Deal-Breaker in Antibody Development

January 6, 2026

Case Study

3D ribbon-like protein structure with yellow segments marking editable regions and grey segments marking non-editable regions. Text on the left reads ‘Intellectual Property Expansion’ with a small color legend for editable and non-editable areas

AI-driven IP expansion: scientific and operational breakthroughs using innovative antibody design

December 3, 2025

Blog

Are binding antibody-antigen affinity values in public datasets reproducible?

August 19, 2025

Research and Updates

Blog

Solubility: The Quiet Deal-Breaker in Antibody Development

January 6, 2026

Case Study

3D ribbon-like protein structure with yellow segments marking editable regions and grey segments marking non-editable regions. Text on the left reads ‘Intellectual Property Expansion’ with a small color legend for editable and non-editable areas

AI-driven IP expansion: scientific and operational breakthroughs using innovative antibody design

December 3, 2025

Resources Page

Research and Updates

Blog

Solubility: The Quiet Deal-Breaker in Antibody Development

January 6, 2026

Case Study

3D ribbon-like protein structure with yellow segments marking editable regions and grey segments marking non-editable regions. Text on the left reads ‘Intellectual Property Expansion’ with a small color legend for editable and non-editable areas

AI-driven IP expansion: scientific and operational breakthroughs using innovative antibody design

December 3, 2025

Blog

Are binding antibody-antigen affinity values in public datasets reproducible?

August 19, 2025

Resources Page